Gossamer Bio, Inc.
GOSS
$2.46
-$0.07-2.77%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.49M | 9.89M | 9.38M | 9.48M | 95.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.49M | 9.89M | 9.38M | 9.48M | 95.84M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 11.49M | 9.89M | 9.38M | 9.48M | 95.84M |
| SG&A Expenses | 8.68M | 8.66M | 9.40M | 8.50M | 8.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.25M | 46.70M | 45.51M | 43.40M | 43.76M |
| Operating Income | -38.77M | -36.81M | -36.13M | -33.92M | 52.09M |
| Income Before Tax | -38.27M | -36.64M | -35.44M | -31.94M | 53.67M |
| Income Tax Expenses | -- | -- | -2.41M | -1.13M | 4.44M |
| Earnings from Continuing Operations | -38.27M | -36.64M | -33.03M | -30.80M | 49.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.27M | -36.64M | -33.03M | -30.80M | 49.23M |
| EBIT | -38.77M | -36.81M | -36.13M | -33.92M | 52.09M |
| EBITDA | -38.76M | -36.80M | -36.02M | -33.70M | 52.34M |
| EPS Basic | -0.17 | -0.16 | -0.29 | -0.14 | 0.22 |
| Normalized Basic EPS | -0.11 | -0.10 | -0.27 | -0.09 | 0.15 |
| EPS Diluted | -0.17 | -0.16 | -0.29 | -0.14 | 0.22 |
| Normalized Diluted EPS | -0.11 | -0.10 | -0.27 | -0.09 | 0.14 |
| Average Basic Shares Outstanding | 227.28M | 226.82M | 226.60M | 226.35M | 226.22M |
| Average Diluted Shares Outstanding | 227.28M | 226.82M | 226.60M | 226.35M | 238.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |